Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IDRA-21 是一种阳性 AMPA 受体调节剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
25 mg | ¥ 198 | 现货 | ||
50 mg | ¥ 289 | 现货 | ||
100 mg | ¥ 463 | 现货 | ||
200 mg | ¥ 676 | 现货 | ||
500 mg | ¥ 1,120 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 150 | 现货 |
产品描述 | IDRA-21 is a positive AMPA receptor modulator. |
体内活性 | Oral administration of IDRA 21 produced a highly significant improvement in the performance of a delayed matching-to-sample (DMTS) task by young adult rhesus monkeys.?The pattern of task improvement over the dose range 0.15-10 mg/kg was maintained to 48 hr after the single dose administration.?For sessions run after administration of the individualized Best Dose of IDRA 21, task accuracy for Long delay (most difficult) trials was increased by 34% of vehicle.?Animals were randomly assigned fixed doses of IDRA 21 to determine whether the positive mnemonic response could be maintained.?The repeated doses were separated by 3 days, thus allowing for potential cumulative effects.?IDRA 21 produced a gradual increase in task accuracy that was maintained on average above vehicle performance levels over an intermittent dosing schedule during a total period of 3 weeks.?A separate group of aged monkeys (>20 y) were, as a group, impaired (during vehicle testing) in DMTS performance efficiency relative to the young cohort.?IDRA 21 also improved task accuracy by aged rhesus monkeys over the same dose range, but the responses were not as robust as those exhibited by young animals.?Aged subjects also appeared to be more individually sensitive to drug dose, and they exhibited shorter task latencies than did the young group[1]. |
别名 | 7-氯-3-甲基-3,4-二氢-2H-1,2,4-苯并噻二嗪 1,1-二氧化物 |
分子量 | 232.69 |
分子式 | C8H9ClN2O2S |
CAS No. | 22503-72-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (107.44 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 4.2976 mL | 21.4878 mL | 42.9756 mL | 107.4391 mL |
5 mM | 0.8595 mL | 4.2976 mL | 8.5951 mL | 21.4878 mL | |
10 mM | 0.4298 mL | 2.1488 mL | 4.2976 mL | 10.7439 mL | |
20 mM | 0.2149 mL | 1.0744 mL | 2.1488 mL | 5.372 mL | |
50 mM | 0.086 mL | 0.4298 mL | 0.8595 mL | 2.1488 mL | |
100 mM | 0.043 mL | 0.2149 mL | 0.4298 mL | 1.0744 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
IDRA-21 22503-72-6 Neuroscience GluR memory Inhibitor IDRA 21 inhibit orally active Ionotropic glutamate receptors aging excitatory neurotransmission cognitive GluR1/2 7-氯-3-甲基-3,4-二氢-2H-1,2,4-苯并噻二嗪 1,1-二氧化物 AMPA IDRA21 iGluR inhibitor